Relmada Therapeutics Inc. (RLMD)
NASDAQ: RLMD
· Real-Time Price · USD
0.61
-0.01 (-1.79%)
At close: Aug 20, 2025, 10:13 AM
Relmada Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 452.00 | 1.26K | 1.26K | 2.11K | 2.69K |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -452 | -1.26K | -1.26K | -1.26K | -806 |
Operating Income | -70.52M | -79.12M | -83.89M | -91.64M | -91.33M | -98.54M | -103.7M | -115.58M | -131.62M | -151.1M | -161.25M | -156.73M | -160.65M | -141.6M | -125.7M | -112.44M | -86.97M | -73.27M |
Interest Income | 2.27M | 2.91M | 3.53M | 4.13M | 4.6M | 5M | 5.15M | 5.01M | 4.51M | 3.54M | 2.66M | 1.54M | 1.01M | 950.4K | 1.04M | 1.04M | 1.11M | 1.19M |
Pretax Income | -67.81M | -75.71M | -79.98M | -86.49M | -86.76M | -94.3M | -98.79M | -111.57M | -128.99M | -143.62M | -157.04M | -153.48M | -156.66M | -143.28M | -125.75M | -112.14M | -86.43M | -71M |
Net Income | -67.81M | -75.71M | -79.98M | -86.49M | -86.76M | -94.3M | -98.79M | -111.57M | -128.99M | -143.62M | -157.04M | -153.48M | -156.66M | -143.28M | -125.75M | -112.14M | -86.43M | -71M |
Selling & General & Admin | 33.6M | 34.3M | 37.72M | 41.72M | 42.1M | 46.29M | 48.9M | 48.65M | 44.62M | 46.93M | 47.93M | 45M | 45.45M | 39.98M | 35.08M | 32.19M | 29.48M | 27.78M |
Research & Development | 36.92M | 44.82M | 46.17M | 49.93M | 49.23M | 52.25M | 54.81M | 66.92M | 87M | 104.17M | 113.32M | 111.73M | 115.19M | 101.61M | 90.62M | 80.25M | 57.49M | 45.49M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 70.52M | 79.12M | 83.89M | 91.64M | 91.33M | 98.54M | 103.7M | 115.58M | 131.62M | 151.1M | 161.25M | 156.73M | 160.65M | 141.6M | 125.7M | 112.44M | 86.97M | 73.27M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 70.52M | 79.12M | 83.89M | 91.64M | 91.33M | 98.54M | 103.7M | 115.58M | 131.62M | 151.1M | 161.25M | 156.73M | 160.65M | 141.6M | 125.7M | 112.44M | 86.97M | 73.27M |
Income Tax Expense | n/a | n/a | n/a | -26.83K | -26.83K | -26.83K | -26.83K | n/a | n/a | -387K | -717K | -876K | -1.17M | -696.94K | -556.94K | -558.94K | -260.94K | -351K |
Shares Outstanding (Basic) | 33.19M | 30.41M | 30.17M | 30.17M | 30.17M | 30.13M | 30.1M | 30.1M | 30.1M | 30.1M | 30.1M | 30.06M | 29.94M | 28.39M | 19.08M | 17.48M | 17.05M | 16.57M |
Shares Outstanding (Diluted) | 33.19M | 30.41M | 30.17M | 30.17M | 30.17M | 30.13M | 30.1M | 30.1M | 30.1M | 30.1M | 30.1M | 30.06M | 29.94M | 28.39M | 19.08M | 17.48M | 17.05M | 16.57M |
EPS (Basic) | -2.22 | -2.51 | -2.65 | -2.87 | -2.88 | -3.13 | -3.28 | -3.7 | -4.28 | -4.77 | -5.3 | -5.84 | -6.97 | -7.2 | -7.14 | -6.62 | -5.23 | -4.4 |
EPS (Diluted) | -2.22 | -2.51 | -2.65 | -2.87 | -2.88 | -3.13 | -3.28 | -3.7 | -4.28 | -4.77 | -5.3 | -5.84 | -6.97 | -7.2 | -7.14 | -6.62 | -5.23 | -4.4 |
EBITDA | -70.11M | -78.7M | -79.56M | -86.07M | -85.06M | -91.63M | -100.71M | -114.25M | -130.98M | -151.1M | -161.25M | -156.92M | -160.84M | -141.79M | -125.9M | -112.28M | -86.81M | -73.1M |
EBIT | -69.75M | -78.7M | -82.31M | -88.82M | -87.81M | -95.02M | -99.52M | -113.05M | -129.79M | -149.27M | -161.25M | -156.73M | -160.65M | -141.6M | -125.7M | -112.28M | -86.81M | -73.11M |
Depreciation & Amortization | 23.01M | 41.83M | 64.81M | 64.81M | 41.81M | 49.02M | 54.18M | 54.18M | 54.18M | 28.15M | n/a | -195.06K | 54.83K | 54.97K | 55.46K | 252.28K | 2.94K | 3.51K |